Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Mangoceuticals (MGRX) Other Gross PP&E Adjustments (2022 - 2025)

Mangoceuticals' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$3.1 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 204.89% to -$3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.1 million, a 204.89% decrease, with the full-year FY2025 number at -$3.1 million, down 204.89% from a year prior.
  • Other Gross PP&E Adjustments hit -$3.1 million in Q4 2025 for Mangoceuticals, down from -$16273.0 in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for MGRX hit a ceiling of -$16273.0 in Q3 2025 and a floor of -$3.1 million in Q4 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$414830.5 across 4 years, with a median of -$163593.0 in 2025.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 667.48% in 2024 and later skyrocketed 91.64% in 2025.
  • Tracing MGRX's Other Gross PP&E Adjustments over 4 years: stood at -$169179.0 in 2022, then tumbled by 38.33% to -$234019.0 in 2023, then plummeted by 330.16% to -$1.0 million in 2024, then tumbled by 204.89% to -$3.1 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for MGRX at -$3.1 million in Q4 2025, -$16273.0 in Q3 2025, and -$32732.0 in Q2 2025.